A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Clinical trial NCT01727726 · COMPLETED

Trial details

NCT number: NCT01727726
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder Depression Depressive Disorder, Major Mood Disorders Mental Disorders

Start date: 2012-12-01
Primary completion: 2016-10-17
Enrollment: 2182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.